Bachem Holding AG logo

Bachem Holding AG (BCHMY)

Market Closed
10 Aug, 20:00
OTC PINK OTC PINK
$
8. 93
+0.18
+2.0583%
$
5.6B Market Cap
- P/E Ratio
0.14% Div Yield
35,862 Volume
- Eps
$ 8.75
Previous Close
Add Transaction
Day Range
8.87 9.51
Year Range
5.97 12.54
Want to track BCHMY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BCHMY closed yesterday higher at $8.93, an increase of 2.0583% from Friday's close, completing a monthly decrease of -9.2008% or -$0.9. Over the past 12 months, BCHMY stock gained 22.4979%.
BCHMY pays dividends to its shareholders, with the most recent payment made on May 20, 2026. The next estimated payment will be in In 9 months on May 20, 2027 for a total of $0.07211.
The last earnings report, released on Feb 25, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

BCHMY Chart

People also search for

Mitsubishi Chemical Group Corporation ADR
$ 37
0%
Boliden AB (publ)
$ 52.9
0%
Voestalpine AG Unsponsored ADR
$ 10.45
0%
BlueScope Steel Ltd.
$ 106.89
0%
Aurubis AG
$ 102.31
-0.1854%
Bachem Holding AG (BCHMY) Q2 2026 Earnings Call Transcript

Bachem Holding AG (BCHMY) Q2 2026 Earnings Call Transcript

Bachem Holding AG (BCHMY) Q2 2026 Earnings Call Transcript

Seekingalpha | 1 week ago
Bachem Holding AG (BCHMY) Q4 2025 Earnings Call Transcript

Bachem Holding AG (BCHMY) Q4 2025 Earnings Call Transcript

Bachem Holding AG (BCHMY) Q4 2025 Earnings Call Transcript

Seekingalpha | 5 months ago

Bachem Holding AG (BCHMY) FAQ

What is the stock price today?

The current price is $8.93.

On which exchange is it traded?

Bachem Holding AG is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is BCHMY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.14%.

What is its market cap?

As of today, the market cap is 5.6B.

Has Bachem Holding AG ever had a stock split?

No, there has never been a stock split.

Bachem Holding AG Profile

Chemicals Industry
Materials Sector
Mr. Thomas Meier CEO
OTC PINK Exchange
CH0012530207 ISIN
Switzerland Country
2,009 Employees
5 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

Bachem Holding AG is a global leader in the pharmaceutical and biotechnology sectors, offering a wide range of products and services for research, clinical development, and commercial application. The company specializes in the development, production, and regulatory support of peptide active pharmaceutical ingredients (APIs), including peptide and oligonucleotide new chemical entities (NCEs). Founded in 1971, Bachem has established its headquarters in Bubendorf, Switzerland, and has since been committed to providing high-quality solutions to its clients worldwide.

Products and Services

  • Peptide and Oligonucleotide NCEs:

    Specializing in the development and production of NCEs, Bachem offers cutting-edge solution for pharmaceutical and biotechnology companies focusing on peptide and oligonucleotide-based drugs. This includes both research and commercial scale products.

  • Commercial NCEs and Generics:

    Bachem supplies a range of commercially available NCEs and generic APIs, catering to the ongoing needs of the healthcare industry for reliable and effective ingredients.

  • Project Management Services:

    The company provides comprehensive project management services, ensuring efficient and timely execution of drug development projects from concept through to commercialization.

  • Quality and Regulatory Support:

    Bachem offers in-depth quality and regulatory support to help clients navigate the complex drug approval processes, ensuring compliance with all applicable regulations and guidelines.

  • Analytical Services:

    With its advanced analytical services, Bachem supports the accurate and precise measurement of pharmaceutical compounds, ensuring they meet the stringent quality standards required in the industry.

  • Good Manufacturing Practice (GMP) Production:

    Bachem’s GMP production services are aligned with international standards, providing clients with high-quality peptides and oligonucleotides suitable for clinical trials and commercial applications.

  • Research Grade Production:

    The company also offers research grade production services, supplying peptides and oligonucleotides for preclinical and early-stage drug development research.

  • Supply and Vertical Integration Services:

    Bachem's supply and vertical integration services ensure the seamless procurement and integration of raw materials, intermediates, and APIs for pharmaceutical and biotech companies, optimizing the supply chain and reducing time to market.

Contact Information

Address: Hauptstrasse 144
Phone: 41 58 595 2021